DNA methylation age (DNAm age) has become a widely utilized epigenetic biomarker 29 for the aging process. The Horvath method for determining DNAm age is perhaps the most 30 widely utilized and validated DNA methylation age assessment measure. Horvath DNAm age is 31 calculated based on methylation measurements at 353 loci which were present on Illumina's 32 450k and 27k DNA methylation microarrays. With the increasing use of the more recently 33 developed Illumina MethylationEPIC (850k) microarray, it is worth revisiting this widely used 34 aging measure to evaluate differences in DNA methylation age estimation based on array design. 35 Of the requisite 353 loci, 17 are missing from the current 850k microarray. Using 17 datasets 36 with 27k, 450k, and/or 850k methylation data, we calculated and compared each sample's 37 epigenetic age estimated from all 353 loci required from the Horvath DNAm age calculator 38 (full), and using only the 336 loci present on the 27k, 450k, and 850k arrays (reduced). In 39 450k/27k data, missing loci caused underestimation of epigenetic age when compared with the 40 full clock. Underestimation of full epigenetic age grew from ages 0 to ~20, remaining stable 41 thereafter (mean= -3.46 y, SD=1.13) years for individuals ≥20 years. Underestimation of DNAm 42 age by the reduced 450k/27k data was similar to the underestimation observed in the 850k data 43 indicating that array differences in DNAm age estimation are primarily driven by missing 44 probes. Correlations between age and DNAm age were not dependent on missing probes or on 45 array designs and consequently associations between DNAm age and outcomes such as sex 46 remained the same independent of missing probes and probe design. In conclusion, DNAm age 47 estimations are array dependent driven by missing probes between arrays. Though correlations 48 and associations with DNAm age may remain the same, researchers should exercise caution 49 when interpreting results based on absolute differences in DNAm age or when mixing samples 50 assayed on different arrays. 3 51
Introduction

52
DNA methylation has recently shown promise as a potentially clinically useful biomarker 53 of aging. A recent "epigenetic clock" developed by Horvath (1) has been shown to be an 54 accurate estimator of age across multiple tissues and populations, and differences between DNA 55 methylation age and chronological age are associated with pathophysiological biomarkers and 56 incident disease (2).
57
The method developed by developed by Horvath (1) (Table 2 ). In addition, we had 568 independent CATHGEN samples that were processed on the 178 850k platform.
179 (Horvath, 2013) , and were not available in GEO. † Because the 17 loci required to complete the epigenetic clock are unavailable on the 850k platform, there is not information for the full epigenetic clock CATHGEN 450k and CATHGEN 850k are not comprised of the same individuals. That is, the underlying sample population is non-overlapping. DNA methylation age on chronological age, by age group, in the full   224 and reduced 450k/27k datasets (GEO and CATHGEN) Figure S1 ), we examined associations between age 238 acceleration and sex, ( 
